Quick answers
- What is Bosaya?
- Bosaya is a brand name of Denosumab, a prescription medicine. The FDA NDC Directory lists 1 Bosaya product in 1 strength and form.
- Who makes Bosaya?
- Biocon Biologics Inc holds the FDA application for Bosaya (BLA761436, approved September 16, 2025).
- Is there a generic or store brand of Bosaya?
- Yes. The FDA NDC Directory lists 7 other products with the same active ingredients, strength and form as a Bosaya product. Ask your pharmacist whether one is right for you.
- Has Bosaya been recalled?
- No recall linked to Bosaya products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Bosaya is
Each Bosaya product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Denosumab · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| denosumab 60 mg/mL injection (subcutaneous) | Bosaya | 7 products, 6 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Denosumab →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761436 | Biocon Biologics Inc | September 16, 2025 | 1 |
Companies that list Bosaya
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Bosaya products.
- Biocon Biologics Inc.1 product
Recalls
No recall linked to Bosaya products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.